Immunosuppression in childhood acute lymphoblastic leukemia after remission induction therapy concerns B not T lymphocytes.
Wlodzimierz
W
Luczynski
Maryna
M
Krawczuk-Rybak
Katarzyna
K
Muszynska-Roslan
Anna
A
Stasiak-Barmuta
Janusz
J
Zak
D015703:Antigens, CD / Q000097:blood*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000276:immunology*; D001402:B-Lymphocytes / Q000187:drug effects*; D002648:Child; D006801:Humans; D007136:Immunoglobulins / Q000097:blood; D007165:Immunosuppression Therapy; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000276:immunology*; D012074:Remission Induction; D013601:T-Lymphocytes / Q000187:drug effects
D015703:Antigens, CD; D000970:Antineoplastic Agents; D007136:Immunoglobulins